Bopindolol Malonate

波吲洛尔丙二酸盐

Report date: 2023/04/25 15:42:34
NME

Base Information

Drug NameBopindolol Malonate
Drug Alias Name丙二酸波羟洛羟Bopindololum纳多洛尔丙二酸波吲洛尔Sandonorm +[6
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta-1 adrenergic receptor antagonists
TargetsBeta-1 adrenergic receptor
Therapy Area/IndicationsHypertensionAngina Pectoris
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesN/A
Active IndicationsHypertensionAngina Pectoris
Inactive IndicationsN/A

Other Information

ATC CodeC07AA17